CN103599505B - A kind of Chinese medicine for the treatment of upper respiratory tract infection - Google Patents
A kind of Chinese medicine for the treatment of upper respiratory tract infection Download PDFInfo
- Publication number
- CN103599505B CN103599505B CN201310580133.6A CN201310580133A CN103599505B CN 103599505 B CN103599505 B CN 103599505B CN 201310580133 A CN201310580133 A CN 201310580133A CN 103599505 B CN103599505 B CN 103599505B
- Authority
- CN
- China
- Prior art keywords
- radix
- respiratory tract
- tract infection
- upper respiratory
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine for the treatment of upper respiratory tract infection, the weight proportion of its each raw material components is: Monochoria korsakowii 13-17, Radix Astragali 6-10, Fructus Jujubae 10-14, Radix Glycyrrhizae 4-8, Radix Saposhnikoviae 6-10, Rhizoma Zingiberis Recens 13-17, logical intestinal fragrant 13-17, Flos Lonicerae 4-8, Pericarpium Citri Reticulatae 10-14, Fructus Forsythiae 10-14, Fructus Momordicae 4-8, Rhizoma Anemarrhenae 6-10, Radix achyranthis asperae (Herba Achyranthis Asperae) 1-5.Clinical Action of Traditional Chinese Drugs of the present invention is splendid, has no side effect, to infectious high heat, and especially upper respiratory tract infection better effects if.
Description
technical field:
The present invention relates generally to the field of Chinese medicines, particularly relates to a kind of Chinese medicine for the treatment of upper respiratory tract infection.
background technology:
Upper respiratory tract infection is called for short upper sense, also known as common cold.It is the general name comprising nasal cavity, pharynx or acute throat inflammation.The upper sense of broad sense is not a medical diagnosis on disease, but one group of disease, comprise common cold, viral pharyngitis, laryngitis, herpangina, pharyngoconjunctival fever, bacterial pharyngotonsillitis.The upper sense of narrow sense, also known as common cold, is modal acute infections of respiratory tract disease, and how in self limiting, but incidence rate is higher.
Doctor trained in Western medicine mainly adopts symptomatic treatment, there is no specific drug so far, and expensive, and curative effect can not be entirely satisfactory.
summary of the invention:
The object of the invention is exactly the defect in order to make up prior art, provides a kind of Chinese medicine for the treatment of upper respiratory tract infection, its good effect, instant effect, reasonable price.
The present invention is achieved by the following technical solutions:
Treat a Chinese medicine for upper respiratory tract infection, it is characterized in that: the weight proportion of its each raw material components is: Monochoria korsakowii 13-17, Radix Astragali 6-10, Fructus Jujubae 10-14, Radix Glycyrrhizae 4-8, Radix Saposhnikoviae 6-10, Rhizoma Zingiberis Recens 13-17, logical intestinal fragrant 13-17, Flos Lonicerae 4-8, Pericarpium Citri Reticulatae 10-14, Fructus Forsythiae 10-14, Fructus Momordicae 4-8, Rhizoma Anemarrhenae 6-10, Radix achyranthis asperae (Herba Achyranthis Asperae) 1-5.
Treat a Chinese medicine for upper respiratory tract infection, it is characterized in that: the weight proportion of its each raw material components is: Monochoria korsakowii 15, the Radix Astragali 8, Fructus Jujubae 12, Radix Glycyrrhizae 6, Radix Saposhnikoviae 8, Rhizoma Zingiberis Recens 15, logical intestinal perfume (or spice) 15, Flos Lonicerae 6, Pericarpium Citri Reticulatae 12, Fructus Forsythiae 12, Fructus Momordicae 6, the Rhizoma Anemarrhenae 8, Radix achyranthis asperae (Herba Achyranthis Asperae) 3.
Advantage of the present invention is:
Clinical Action of Traditional Chinese Drugs of the present invention is splendid, has no side effect, to infectious high heat, and especially upper respiratory tract infection (containing bacteriovirus infection) better effects if.
detailed description of the invention:
Treat a Chinese medicine for upper respiratory tract infection, the weight (g) of its each raw material components is: Monochoria korsakowii 15, the Radix Astragali 8, Fructus Jujubae 12, Radix Glycyrrhizae 6, Radix Saposhnikoviae 8, Rhizoma Zingiberis Recens 15, logical intestinal perfume (or spice) 15, Flos Lonicerae 6, Pericarpium Citri Reticulatae 12, Fructus Forsythiae 12, Fructus Momordicae 6, the Rhizoma Anemarrhenae 8, Radix achyranthis asperae (Herba Achyranthis Asperae) 3.
Take above raw material components, according to the routine fashion of decoction, add water and boil decoction and take, every day potion, potion is taken at twice.
For proving that the present invention has good curative effect, enumerate model case as follows:
Case one:
Zhao, man, 31 years old.Cold cough is after high hot 1 week, invalid through quiet of antiinflammatory antiviral, takes Chinese medicine of the present invention and namely heals for 2 days.
Case two:
Wei, female, 28 years old.Puerperal high fever 39-40.5 degree Celsius, invalid after more treat one week than medicines such as woodss with antiinflammatory, take treatment by Chinese herbs of the present invention 2 days, heat is moved back as usual.
Case three:
Lee, man, 12 years old.Suffer from more than pharyngitis two weeks, period takes antibiotic medicine, does not heal always.Give Chinese medicine of the present invention after 3 days, patient cures.
Claims (2)
1. treat a Chinese medicine for upper respiratory tract infection, it is characterized in that: the weight proportion of its each raw material components is: Monochoria korsakowii 13-17, Radix Astragali 6-10, Fructus Jujubae 10-14, Radix Glycyrrhizae 4-8, Radix Saposhnikoviae 6-10, Rhizoma Zingiberis Recens 13-17, logical intestinal fragrant 13-17, Flos Lonicerae 4-8, Pericarpium Citri Reticulatae 10-14, Fructus Forsythiae 10-14, Fructus Momordicae 4-8, Rhizoma Anemarrhenae 6-10, Radix achyranthis asperae (Herba Achyranthis Asperae) 1-5.
2. a kind of Chinese medicine for the treatment of upper respiratory tract infection according to claim 1, is characterized in that: the weight proportion of its each raw material components is: Monochoria korsakowii 15, the Radix Astragali 8, Fructus Jujubae 12, Radix Glycyrrhizae 6, Radix Saposhnikoviae 8, Rhizoma Zingiberis Recens 15, logical intestinal perfume (or spice) 15, Flos Lonicerae 6, Pericarpium Citri Reticulatae 12, Fructus Forsythiae 12, Fructus Momordicae 6, the Rhizoma Anemarrhenae 8, Radix achyranthis asperae (Herba Achyranthis Asperae) 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310580133.6A CN103599505B (en) | 2013-11-19 | 2013-11-19 | A kind of Chinese medicine for the treatment of upper respiratory tract infection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310580133.6A CN103599505B (en) | 2013-11-19 | 2013-11-19 | A kind of Chinese medicine for the treatment of upper respiratory tract infection |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103599505A CN103599505A (en) | 2014-02-26 |
CN103599505B true CN103599505B (en) | 2016-04-06 |
Family
ID=50117811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310580133.6A Active CN103599505B (en) | 2013-11-19 | 2013-11-19 | A kind of Chinese medicine for the treatment of upper respiratory tract infection |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103599505B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106110255A (en) * | 2016-07-22 | 2016-11-16 | 铜陵宏正网络科技有限公司 | A kind of medicament treating upper respiratory tract infection |
CN106729531A (en) * | 2016-12-12 | 2017-05-31 | 梁健宁 | A kind of Chinese medicine for treating pulmonary infection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101721607A (en) * | 2009-11-26 | 2010-06-09 | 申忠良 | Chinese medicinal beverage for body building and flu resistance |
CN102772778A (en) * | 2012-08-20 | 2012-11-14 | 刘海霞 | Chinese medicinal composition for treating summer heat-dampness |
-
2013
- 2013-11-19 CN CN201310580133.6A patent/CN103599505B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101721607A (en) * | 2009-11-26 | 2010-06-09 | 申忠良 | Chinese medicinal beverage for body building and flu resistance |
CN102772778A (en) * | 2012-08-20 | 2012-11-14 | 刘海霞 | Chinese medicinal composition for treating summer heat-dampness |
Non-Patent Citations (1)
Title |
---|
桂枝汤加味治疗迁延性上呼吸道感染62例;康忠禹等;《现代中医药》;20100531;第30卷(第03期);23-24 * |
Also Published As
Publication number | Publication date |
---|---|
CN103599505A (en) | 2014-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103341103B (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis and preparation method thereof | |
CN103505654A (en) | Compound traditional Chinese medicine preparation for resisting influenza viruses | |
CN103446505B (en) | Traditional Chinese medicine composition for treating tuberculosis | |
CN102743714B (en) | A kind of Chinese medicine composition for the treatment of for tonifying Qi and nourishing Yin pneumonia | |
CN103599505B (en) | A kind of Chinese medicine for the treatment of upper respiratory tract infection | |
CN102688444B (en) | Traditional Chinese medicine for treating upper respiratory tract infection and preparation method thereof | |
CN103505652A (en) | Traditional Chinese medicine composition used for treating children cough with lung heat | |
CN103285221A (en) | Traditional Chinese medicine for clearing away heat and toxic materials | |
CN103272138A (en) | Traditional Chinese medicine for treating rubella | |
CN103599332B (en) | A kind of Chinese medicine for the treatment of acute bronchitis | |
CN101181437B (en) | Chinese medicine composition orally taken for curing acute tonsillitis | |
CN102696822A (en) | Cold preventing and curing tea | |
CN102940725B (en) | Traditional Chinese medicine composition for treating viral cold | |
CN103566298B (en) | Plaster with wind dispelling and dampness eliminating effects | |
CN104274814A (en) | Traditional Chinese medicine for treating upper respiratory infection | |
CN104547249A (en) | Traditional Chinese medicine for treating acute tonsillitis | |
CN104288265A (en) | Traditional Chinese medicinal composition for treating acute laryngitis | |
CN104107405A (en) | Traditional Chinese medicinal prescription for treating swine influenza | |
CN103099864A (en) | Pharmaceutical composition for treating pharyngolaryngitis and preparation method thereof | |
CN103599241B (en) | Traditional Chinese medicine for treating rubella | |
CN103099906B (en) | Traditional Chinese medicine composition for treating acute mastitis | |
CN103656083A (en) | Traditional Chinese medicine composition for treating costal chondritis | |
CN104645006A (en) | Traditional Chinese medicine prescription for acute pharyngitis | |
CN104116903A (en) | Traditional Chinese medicine for treating acute upper respiratory infection | |
CN102973823B (en) | Chinese traditional medicine for cold-pungent diaphoresis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |